Celldex Therapeutics Inc (CLDX)
53.40
-1.61 -2.93%
NASDAQ
Sep 28, 16:00
53.40
0.00 0.00%
After-Hours: 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 8.618M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.67 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -66.04M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -384.3% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 2.482B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 245.00 |
| PE Ratio | -- |
| Price to Book Value | 13.62 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -12.07M |
| Return on Equity | Upgrade |
View All CLDX News
News
-
WireHeadlineTime (ET)
-
Globe Newswire09/24 07:01
-
Globe Newswire09/23 08:01
-
MT Newswires09/17 09:39
-
Yahoo09/16 07:01
-
Yahoo09/14 10:31
-
MT Newswires09/13 13:43
-
MT Newswires09/13 09:49
-
Globe Newswire09/13 09:01
-
MT Newswires09/10 11:15
-
Yahoo08/25 15:55
-
MT Newswires08/06 09:02
-
Yahoo08/05 18:05
-
MT Newswires08/05 16:03
-
MT Newswires08/05 16:03
-
Yahoo08/05 16:01
-
Yahoo07/29 15:05
-
Yahoo07/24 07:04
-
MT Newswires07/22 07:56
-
Yahoo07/18 03:39
-
MT Newswires07/16 16:11
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 11/05/2021 | Earnings Results | Q3 2021 Earnings Results |
| 08/05/2021 | Earnings Results | Q2 2021 Earnings Results |
| 06/17/2021 09:00 EST | AGM | 2020 Annual General Meeting |
| 05/06/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/29/2021 | Earnings Results | Q4 2020 Earnings Results |
| 11/05/2020 | Earnings Results | Q3 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
- URL: https://www.celldex.com
- Investor Relations URL: https://ir.celldex.com
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Nov. 05, 2021
- Last Earnings Release: Aug. 05, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 53.40 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ETCHX | Eventide Healthcare & Life Sciences C | 3.32% |
| PBE | Invesco Dynamic Biotech & Genome ETF | 3.05% |
| DWAS | Invesco DWA SmallCap Momentum ETF | 2.61% |
| LYFCX | AlphaCentric LifeSci Healthcare C | 2.47% |
| QMOM | Alpha Architect US Quantitative Momt ETF | 2.14% |
| PTH | Invesco DWA Healthcare Momentum ETF | 1.87% |
| MOPRX | MainStay WMC Small Companies R1 | 1.62% |
| BBC | Virtus LifeSci Biotech Clinical Trls ETF | 1.12% |
| FIJYX | Fidelity Advisor® Biotechnology Z | 1.01% |
| IWC | iShares Micro-Cap ETF | 0.47% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
